Varun Medimpex Inc. Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Varun Medimpex Inc. Pharmaceutical Export Portfolio Dataset — 2 Products, $1.6M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Varun Medimpex Inc. — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.6M Trade | TransData Nexus

Varun Medimpex Inc.

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $1.6M Total Trade · DGFT Verified

Varun Medimpex Inc. is an Indian pharmaceutical exporter with a total trade value of $1.6M across 2 products in 2 therapeutic categories. Based on 91 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Dettol ($1.0M), Strip ($589.8K), .

Varun Medimpex Inc. — Export Portfolio & Destination Treemap

Varun Medimpex Inc. pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Varun Medimpex Inc.? — Company Overview & Market Position

Varun Medimpex Inc. is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established nearly two decades ago, the company was founded by Yogesh Gupta, Varun Gupta, and Rajneesh Gupta, who brought extensive experience from the medical devices industry. Their vision was to provide comprehensive solutions in product innovation and manufacturing for the medical sector.

The company's headquarters are located in Kala Amb, Sirmaur District, Himachal Pradesh, India. Varun Medimpex Inc. operates as a privately held entity, with ownership details not publicly disclosed. The Corporate Identification Number (CIN) is not specified in the available sources. While specific revenue figures are not publicly available, the company has demonstrated a consistent export performance, with a total export value of $1.6 million USD and 91 shipments across two therapeutic categories.

What Does Varun Medimpex Inc. Export? — Product Portfolio Analysis

Top Products by Export Value

1Dettol$1.0M 2

Product Portfolio — Top 2 by Export Value

Varun Medimpex Inc. exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Dettol	Brand Names & OTC Products	$1.0M	58	9.1%	4
2	Strip	Medical Devices & Diagnostics	$589.8K	33	0.3%	13

Varun Medimpex Inc. exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $1.6M. The top category is Brand Names & OTC Products (63.8% of portfolio), followed by Medical Devices & Diagnostics (36.2%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Varun Medimpex Inc. — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Varun Medimpex Inc. operates manufacturing facilities in Kala Amb, Sirmaur District, Himachal Pradesh, India. The company has been granted a 'Consent to Establish' (expansion) by the Himachal Pradesh State Pollution Control Board, indicating compliance with environmental regulations. The consent was issued on July 4, 2023, with an expiry date of July 3, 2024.

3Key Leadership

The available sources do not provide specific information regarding the current CEO, CFO, or other key executives of Varun Medimpex Inc. The company's leadership includes founders Yogesh Gupta, Varun Gupta, and Rajneesh Gupta, who have been instrumental in establishing and guiding the company's strategic direction.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Varun Medimpex Inc. Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Varun Medimpex Inc. has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has engaged in Original Equipment Manufacturing (OEM) for multinational corporations, indicating adherence to international quality standards. Specific regulatory filings, approvals, and market access statuses in these regions are not detailed in the available sources.

2Emerging Markets

Varun Medimpex Inc. has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's export data indicates shipments to countries such as Sri Lanka, Taiwan, Indonesia, South Korea, and the United Arab Emirates. While the company has been granted a 'Consent to Establish' by the Himachal Pradesh State Pollution Control Board, specific details regarding WHO prequalification or other certifications enabling access to these markets are not available in the provided sources.

3Geographic Strategy

Varun Medimpex Inc. has demonstrated a diversified geographic strategy by exporting to multiple countries across different continents. The company's export data reveals shipments to Sri Lanka, Taiwan, Indonesia, South Korea, and the United Arab Emirates. This diversification suggests a strategic approach to mitigate concentration risk and leverage opportunities in various markets. However, the company's portfolio concentration is high, with the top five products accounting for 100% of the export value, indicating a need for product diversification to enhance resilience.

Varun Medimpex Inc. — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Varun Medimpex Inc.'s FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not available in the provided sources. The company's engagement in Original Equipment Manufacturing (OEM) for multinational corporations suggests adherence to international quality standards, which may facilitate regulatory approvals in various markets.

2WHO & EU GMP

The available sources do not provide specific information regarding Varun Medimpex Inc.'s WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. The company's focus on OEM for multinational corporations implies compliance with stringent quality standards, which may align with WHO and EU GMP requirements.

3CDSCO & Indian Regulatory

Varun Medimpex Inc. has been granted a 'Consent to Establish' (expansion) by the Himachal Pradesh State Pollution Control Board, indicating compliance with environmental regulations. The consent was issued on July 4, 2023, with an expiry date of July 3, 2024. Specific details regarding Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not available in the provided sources.

Varun Medimpex Inc. — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Varun Medimpex Inc. operates in the competitive pharmaceutical export market, focusing on finished pharmaceutical formulations. The company's export data indicates shipments to countries such as Sri Lanka, Taiwan, Indonesia, South Korea, and the United Arab Emirates. While specific competitors in overlapping categories are not detailed in the available sources, the company's engagement in Original Equipment Manufacturing (OEM) for multinational corporations suggests a competitive positioning in the market.

2Key Differentiators

Varun Medimpex Inc.'s key differentiators include its specialization in Original Equipment Manufacturing (OEM) for multinational corporations, indicating adherence to international quality standards. The company's product portfolio includes bandages, N95 masks, I.V dressings, 3-ply surgical masks, large wound dressings, long strips, surgical tape, Virobar soft masks, and hydrocolloid products. Additionally, the company's manufacturing facility in Kala Amb, Sirmaur District, Himachal Pradesh, has been granted a 'Consent to Establish' (expansion) by the Himachal Pradesh State Pollution Control Board, indicating compliance with environmental regulations.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Varun Medimpex Inc. as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Varun Medimpex Inc. has demonstrated a consistent export performance, with a total export value of $1.6 million USD and 91 shipments across two therapeutic categories. The company's engagement in Original Equipment Manufacturing (OEM) for multinational corporations indicates a reliable track record in product quality and manufacturing processes. The manufacturing facility in Kala Amb, Sirmaur District, Himachal Pradesh, has been granted a 'Consent to Establish' (expansion) by the Himachal Pradesh State Pollution Control Board, indicating compliance with environmental regulations.

2Certifications to Verify

Importers should verify the following certifications when considering Varun Medimpex Inc. as a supplier:

FDA Facility Registration: To confirm compliance with U.S. Food and Drug Administration regulations. Verification can be done through the FDA's official website.

WHO-GMP Certification: To ensure adherence to World Health Organization Good Manufacturing Practices. Verification can be done through the WHO's official website.

Frequently Asked Questions — Varun Medimpex Inc.

How many pharmaceutical products does Varun Medimpex Inc. export from India?

Varun Medimpex Inc. exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Dettol ($1.0M), Strip ($589.8K). Total export value is $1.6M.

What is Varun Medimpex Inc.'s total pharmaceutical export value?

Varun Medimpex Inc.'s total pharmaceutical export value is $1.6M, based on 91 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Varun Medimpex Inc. cover?

Varun Medimpex Inc. exports across 2 therapeutic categories. The largest are Brand Names & OTC Products (63.8%, 1 products), Medical Devices & Diagnostics (36.2%, 1 products).

Get Full Varun Medimpex Inc. Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.